TABLE OF CONTENTS
Volume 56, Issue S71 (July 1999)
State of the Art: Review of Lipids and Progressive Renal Disease |
Lipids as a Risk Factor for Renal Disease |
Mechanisms of Lipid – Induced Renal Injury |
Intracellular Regulation of Inflammation |
Modulation of Responses to Injury by Lipid – Lowering Strategies |
Treatment of Dyslipidemia in Renal Disease |
Treatment of Dyslipidemia in Esrd |
Future Clinical Directions |
Brief Scientific Presentations
Introduction
Introduction FREE
William F Keane, Susumu Yukawa and Masatoshi Mune
Kidney Int 56: S1-S1; doi:10.1046/j.1523-1755.1999.07100.x
State of the Art: Review of Lipids and Progressive Renal Disease
Recent advances in statins and the kidney FREE
Hiroaki Oda and William F Keane
Kidney Int 56: S2-S5; doi:10.1046/j.1523-1755.1999.07101.x
Lipopheresis in the nephrotic syndrome FREE
Carol Brunton, Zachariah Varghese and John F Moorhead
Kidney Int 56: S6-S9; doi:10.1046/j.1523-1755.1999.07102.x
Lipids as a Risk Factor for Renal Disease
Association between hyperlipidemia and microalbuminuria in essential hypertension FREE
Vito M Campese, Stefano Bianchi and Roberto Bigazzi
Kidney Int 56: S10-S13; doi:10.1038/sj.ki.4495390
Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease FREE
Per-Ola Attman, Petar Alaupovic and Ola Samuelsson
Kidney Int 56: S14-S17; doi:10.1046/j.1523-1755.1999.07104.x
New insights into lipid metabolism in the nephrotic syndrome FREE
George A Kaysen and Monique G M De Sain-Van Der Velden
Kidney Int 56: S18-S21; doi:10.1046/j.1523-1755.1999.07105.x
Lipoprotein abnormalities in diabetic nephropathy FREE
Tsutomu Hirano
Kidney Int 56: S22-S24; doi:10.1046/j.1523-1755.1999.07106.x
Apolipoprotein E polymorphism and renal disease FREE
Hiroaki Oda, Noriaki Yorioka, Chikako Ueda, Shigeyuki Kushihata and Michio Yamakido
Kidney Int 56: S25-S27; doi:10.1046/j.1523-1755.1999.07107.x
Role of circulating lipid abnormalities in chronic renal allograft rejection FREE
Bertram L Kasiske
Kidney Int 56: S28-S30; doi:10.1046/j.1523-1755.1999.07108.x
Mechanisms of Lipid – Induced Renal Injury
Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy FREE
Karin Jandeleit-Dahm, Zemin Cao, Alison J Cox, Darren J Kelly, Richard E Gilbert and Mark E Cooper
Kidney Int 56: S31-S36; doi:10.1046/j.1523-1755.1999.07109.x
Lipoprotein glomerulopathy: Significance of lipoprotein and ultrastructural features FREE
Takao Saito, Shinichi Oikawa, Hiroshi Sato, Toshinobu Sato, Sadayoshi Ito and Jun Sasaki
Kidney Int 56: S37-S41; doi:10.1046/j.1523-1755.1999.07110.x
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable FREE
Eric De Boer, Gerjan Navis, Frits-Hein Wapstra, Paul E De Jong and Dick De Zeeuw
Kidney Int 56: S42-S46; doi:10.1038/sj.ki.4495398
Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury FREE
Motoshi Hattori, David J Nikolic-Paterson, Kenichi Miyazaki, Nicole M Isbel, Hui Y Lan, Robert C Atkins, Hiroshi Kawaguchi and Katsumi Ito
Kidney Int 56: S47-S50; doi:10.1046/j.1523-1755.1999.07112.x
Effect of lipoproteins on mesangial cell proliferation FREE
Yoji Nishida, Hiroaki Oda and Noriaki Yorioka
Kidney Int 56: S51-S53; doi:10.1046/j.1523-1755.1999.07113.x
Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy FREE
Toshio Miyata, Satoshi Sugiyama, Daisuke Suzuki, Reiko Inagi and Kiyoshi Kurokawa
Kidney Int 56: S54-S56; doi:10.1046/j.1523-1755.1999.07114.x
Endothelial function in proteinuric renal disease FREE
Jaap A Joles, Erik S G Stroes and Ton J Rabelink
Kidney Int 56: S57-S61; doi:10.1046/j.1523-1755.1999.07115.x
Atherogenic lipoproteins, oxidative stress, and cell death FREE
Jan Galle, Kathrin Heermeier and Christoph Wanner
Kidney Int 56: S62-S65; doi:10.1046/j.1523-1755.1999.07116.x
Vitamin E treatment of experimental glomerular disease in rats FREE
Haruhisa Otani, Masatoshi Mune, Susumu Yukawa, Donald Smith, Mohsen Meydani and Jeffrey Blumberg
Kidney Int 56: S66-S69; doi:10.1046/j.1523-1755.1999.07117.x
Intracellular Regulation of Inflammation
Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells FREE
Vaijinath S Kamanna, Babu V Bassa, Nosratola D Vaziri and Daeyoung D Roh
Kidney Int 56: S70-S75; doi:10.1046/j.1523-1755.1999.07118.x
The central role of nuclear factor-
B in mesangial cell activation FREE
Ziad A Massy, Carlos Guijarro, Micheal P O'Donnell, Youngki Kim, Clifford E Kashtan, Jesús Egido, Bertram L Kasiske and William F Keane
Kidney Int 56: S76-S79; doi:10.1046/j.1523-1755.1999.07119.x
Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis FREE
Ziad A Massy, Carlos Guijarro, Hiroaki Oda, Bertram L Kasiske, William F Keane and Michael P O'Donnell
Kidney Int 56: S80-S83; doi:10.1038/sj.ki.4495407
Modulation of Responses to Injury by Lipid – Lowering Strategies
Effect of simvastatin on proliferative nephritis and cell-cycle protein expression FREE
Ashio Yoshimura, Takashi Nemoto, Youichi Sugenoya, Kiyoko Inui, Susumu Watanabe, Yoshihiko Inoue, Sakineh Sharif, Naoko Yokota, Susumu Uda, Hiroyuki Morita and Terukuni Ideura
Kidney Int 56: S84-S87; doi:10.1046/j.1523-1755.1999.07121.x
Lipophilic statins induce apoptosis of human vascular smooth muscle cells FREE
Carlos Guijarro, Luis Miguel Blanco-Colio, Ziad A Massy, Michael P O'Donnell, Bertram L Kasiske, William F Keane and Jesús Egido
Kidney Int 56: S88-S91; doi:10.1038/sj.ki.4495409
Effect of lipid-lowering strategies on tubular cell biology FREE
François Vrtovsnik, Marie Essig, Osamu Iimura and Gérard Friedlander
Kidney Int 56: S92-S96; doi:10.1046/j.1523-1755.1999.07123.x
Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation FREE
Motonobu Nishimura, Tomoaki Tanaka, Tatsuji Yasuda, Shinichi Kurakata, Masatoshi Kitagawa, Kenichi Yamada, Yasushi Saito and Aizan Hirai
Kidney Int 56: S97-S100; doi:10.1046/j.1523-1755.1999.07124.x
Treatment of Dyslipidemia in Renal Disease
Progression of diabetic nephropathy in normotensive type 1 diabetic patients FREE
Peter Jacobsen, Kasper Rossing, Lise Tarnow, Peter Rossing, Christine Mallet, Odette Poirier, Francois Cambien and Hans-Henrik Parving
Kidney Int 56: S101-S105; doi:10.1046/j.1523-1755.1999.07125.x
Atherosclerotic nephropathy FREE
John E Scoble
Kidney Int 56: S106-S109; doi:10.1046/j.1523-1755.1999.07126.x
Lipid-lowering therapy in membranous nephropathy FREE
Martin Haas, Dontscho Kerjaschki and Gert Mayer
Kidney Int 56: S110-S112; doi:10.1046/j.1523-1755.1999.07127.x
Simvastatin in nephrotic syndrome FREE
Christoph J Olbricht, Christoph Wanner, Joachim Thiery, Achim Basten and for the Simvastatin In Nephrotic Syndrome Study Group
Kidney Int 56: S113-S116; doi:10.1046/j.1523-1755.1999.07128.x
Effect of HMG-CoA reductase inhibitors on chronic allograft rejection FREE
Steven Katznelson
Kidney Int 56: S117-S121; doi:10.1046/j.1523-1755.1999.07129.x
Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome FREE
Eri Muso, Masatoshi Mune, Yasuhiro Fujii, Enyu Imai, Naohiko Ueda, Kazuhiro Hatta, Akio Imada, Shozo Miki, Takashi Kuwahara, Yoshihiro Takamitsu, Tsukasa Takemura and Yoshiharu Tsubakihara for the Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group
Kidney Int 56: S122-S125; doi:10.1046/j.1523-1755.1999.07130.x
Treatment of Dyslipidemia in Esrd
Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients FREE
Masatoshi Mune, Susumu Yukawa, Masanori Kishino, Haruhisa Otani, Keigo Kimura, Osamu Nishikawa, Toshio Takahashi, Naoya Kodama, Yasushi Saika and Yoichi Yamada
Kidney Int 56: S126-S129; doi:10.1046/j.1523-1755.1999.07102.x
Acute myocardial infarction in patients with end-stage renal disease FREE
Charles A Herzog
Kidney Int 56: S130-S133; doi:10.1046/j.1523-1755.1999.07132.x
Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients FREE
Yoshiki Nishizawa, Tetsuo Shoji, Tsutomu Tabata, Takashi Inoue and Hirotoshi Morii
Kidney Int 56: S134-S136; doi:10.1046/j.1523-1755.1999.07133.x
Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients FREE
Zac Varghese, Ray L Fernando, Gita Turakhia, Erasmia Psimenou, Oswald N Fernando, Paul Sweny, Stephen H Powis and John F Moorhead
Kidney Int 56: S137-S140; doi:10.1046/j.1523-1755.1999.07134.x
Future Clinical Directions
Ongoing clinical trials of lipid reduction therapy in patients with renal disease FREE
Susumu Yukawa, Masatoshi Mune, Yoichi Yamada, Haruhisa Otani, Masanori Kishino and Yoshinori Tone
Kidney Int 56: S141-S143; doi:10.1046/j.1523-1755.1999.07135.x
Brief Scientific Presentations
Clinicopathological characteristics of interstitial foam cells in membranous nephropathy FREE
Isao Kurihara, Takao Saito, Jun Soma, Hiroshi Sato, Osamu Hotta, Yoshio Taguma and Sadayoshi Ito
Kidney Int 56: S144-S146; doi:10.1046/j.1523-1755.1999.07136.x
Evaluation of serum lipid abnormalities in chronic nephritis FREE
Hiroko Hirano, Yoichi Yamada, Haruhisa Otani, Naoya Kodama, Masatoshi Mune and Susumu Yukawa
Kidney Int 56: S147-S149; doi:10.1046/j.1523-1755.1999.07137.x
A high-fat diet aggravates tubulointerstitial but not glomerular lesions in obese Zucker rats FREE
Sanae Matsuda, Takami Arai, Kazuko Iwata, Megumi Oka and Mitsumasa Nagase
Kidney Int 56: S150-S152; doi:10.1046/j.1523-1755.1999.07138.x
Imaging of hydroperoxides in a rat glomerulus stimulated by puromycin aminonucleoside FREE
Kazumasa Aoyagi, Kayo Akiyama, Chie Tomida, Mitihiro Gotoh, Aki Hirayama, Katsumi Takemura, Atsushi Ueda, Sohji Nagase, Akio Koyama and Mitsuharu Narita
Kidney Int 56: S153-S155; doi:10.1046/j.1523-1755.1999.07139.x
Lysophosphatidylcholine up-regulates IL-1
-induced iNOS expression in rat mesangial cells FREE
Mayumi Taniuchi, Haruhisa Otani, Naoya Kodama, Yoshinori Tone, Michiko Sakagashira, Yoichi Yamada, Masatoshi Mune and Susumu Yukawa
Kidney Int 56: S156-S158; doi:10.1046/j.1523-1755.1999.07140.x
Lipid-binding proteins in rat and human kidney FREE
Hideki Kimura, Hiroshi Fujii, Satoru Suzuki, Teruo Ono, Masaaki Arakawa and Fumitake Gejyo
Kidney Int 56: S159-S162; doi:10.1046/j.1523-1755.1999.07141.x
Human mesangial cells express inducible macrophage scavenger receptor: an Ap-1 and ets mediated response FREE
Xiong Z Ruan, Zac Varghese, Stephen H Powis and John F Moorhead
Kidney Int 56: S163-S166; doi:10.1038/sj.ki.4495429
Probucol suppresses ICAM-1 expression in rat mesangial cells: Possible role of IL-1 FREE
Toshihiro Sugiura, Akira Wada, Toshiki Moriyama, Masaru Horio, Naohiko Ueda, Enyu Imai and Masatsugu Hori
Kidney Int 56: S167-S170; doi:10.1046/j.1523-1755.1999.07143.x
Phospholipase A2 activity in ox-LDL-stimulated mesangial cells and modulation by 
-tocopherol FREE
Mituru Ozaki, Yoichi Yamada, Katsumi Matoba, Haruhisa Otani, Masatoshi Mune, Susumu Yukawa and Wataru Sakamoto
Kidney Int 56: S171-S173; doi:10.1046/j.1523-1755.1999.07144.x
Brief Scientific Presentations
Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats FREE
Naoya Kodama, Haruhisa Otani, Yoichi Yamada, Masatoshi Mune and Susumu Yukawa
Kidney Int 56: S174-S177; doi:10.1046/j.1523-1755.1999.07102.x
Brief Scientific Presentations
Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy FREE
Tamotsu Yokota, Kazunori Utsunomiya, Yuichi Murakawa, Hideaki Kurata and Naoko Tajima
Kidney Int 56: S178-S181; doi:10.1046/j.1523-1755.1999.07146.x
Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line FREE
Yoshinori Tone, Susumu Yukawa, Zac Varghese and John F Moorhead
Kidney Int 56: S182-S185; doi:10.1046/j.1523-1755.1999.07147.x
A common mutation of cholesteryl ester transfer protein gene in dialysis patients FREE
Hideki Kimura, Fumitake Gejyo, Satoru Suzuki, Tomoko Yamaguchi, Toshio Imura, Ryoichi Miyazaki, Kyoko Ei, Isei Ei, Mizue Oda, Yoshiichi Miyakawa and Masaaki Arakawa
Kidney Int 56: S186-S189; doi:10.1046/j.1523-1755.1999.07148.x
Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats FREE
Minoru Yamakado and Michihito Ise
Kidney Int 56: S190-S192; doi:10.1046/j.1523-1755.1999.07149.x
Oral adsorbent ameliorates renal TGF-1 expression in hypercholesterolemic rats FREE
Isao Aoyama, Takashi Miyazaki, Fumio Takayama, Saori Tsukushi, Shinsuke Saga, Kaoru Shimokata and Toshimitsu Niwa
Kidney Int 56: S193-S197; doi:10.1046/j.1523-1755.1999.07150.x
Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells FREE
Fumiaki Nogaki, Eri Muso, Masatomo Yashiro, Kenji Kasuno, Tadashi Kamata, Takahiko Ono and Shigetake Sasayama
Kidney Int 56: S198-S201; doi:10.1046/j.1523-1755.1999.07151.x
Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells FREE
Hiroaki Oda, Bertram L Kasiske, Michael P O'Donnell and William F Keane
Kidney Int 56: S202-S205; doi:10.1046/j.1523-1755.1999.07152.x
Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy FREE
Toshiyuki Nakao, Maki Yoshino, Hiroshi Matsumoto, Tomonari Okada, Myongi Han, Hiromi Hidaka, Tamami Shino, Chikayuki Yamada, Yume Nagaoka and Tadashi Miyahara
Kidney Int 56: S206-S209; doi:10.1046/j.1523-1755.1999.07153.x
Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome FREE
Mari Sakurai, Eri Muso, Hiroyuki Matushima, Takahiko Ono and Shigetake Sasayama
Kidney Int 56: S210-S212; doi:10.1038/sj.ki.4495441
Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients FREE
Tetsuya Goto, Hiroko Saika, Toshio Takahashi, Akefumi Maeda, Masatoshi Mune and Susumu Yukawa
Kidney Int 56: S213-S215; doi:10.1046/j.1523-1755.1999.07155.x
Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis FREE
Takashi Sakurai, Hiroyuki Akiyama, Toru Oka, Kenn-Ichi Sekita, Koichi Yokono and Takeo Goto
Kidney Int 56: S216-S218; doi:10.1046/j.1523-1755.1999.07156.x
Effect of simvastatin on the lipid profile of hemodialysis patients FREE
Osamu Nishikawa, Masatoshi Mune, Motoshige Miyano, Takahiro Nishide, Iwao Nishide, Akifumi Maeda, Keigo Kimura, Toshio Takahashi, Masanori Kishino, Yoshinori Tone, Haruhisa Otani, Akio Ogawa, Takao Maeda and Susumu Yukawa
Kidney Int 56: S219-S221; doi:10.1046/j.1523-1755.1999.07157.x
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis FREE
Christoph Wanner, Vera Krane, Günther Ruf, Winfried März, Eberhard Ritz and for Die Deutsche Diabetes Dialyse Studie Investigators
Kidney Int 56: S222-S226; doi:10.1046/j.1523-1755.1999.07158.x
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients FREE
Keiko Oi, Tsutomu Hirano, Soichi Sakai, Yoshindo Kawaguchi and Tatsuo Hosoya
Kidney Int 56: S227-S228; doi:10.1046/j.1523-1755.1999.07159.x
Effect of probucol on hypercholesterolemia in renal transplant patients FREE
Michihito Okubo, Makoto Nakamura, Akira Horii, Kouju Kamata, Yasuo Takeuchi, Yusuke Tsukamoto, Naoyuki Kobayashi, Koshi Sato and Tadao Endo
Kidney Int 56: S229-S230; doi:10.1046/j.1523-1755.1999.07160.x
Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients FREE
Alberto Martínez-Castelao, Josep M Grinyó, Concepció Fiol, María J Castiñeiras, Isabel Hurtado, Salvador Gil-Vernet, Daniel Serón, Isidre Porta, Antonio Miñarro, Angel Villarroya and Jeroni Alsina
Kidney Int 56: S231-S234; doi:10.1046/j.1523-1755.1999.07161.x
Immunosuppression enhances atherogenicity of lipid profile after transplantation FREE
Thomas Quaschning, Till Mainka, Matthias Nauck, Lars Christian Rump, Christoph Wanner and Annette Krämer-Guth
Kidney Int 56: S235-S237; doi:10.1046/j.1523-1755.1999.07162.x
Factors associated with calcification of the abdominal aorta in hemodialysis patients FREE
Keigo Kimura, Yasushi Saika, Haruhisa Otani, Ryouichi Fujii, Masatoshi Mune and Susumu Yukawa
Kidney Int 56: S238-S241; doi:10.1046/j.1523-1755.1999.07163.x
Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients FREE
Hiroshige Ohashi, Hiroshi Oda, Michiya Ohno, Sachiro Watanabe and Shigeki Sakata
Kidney Int 56: S242-S244; doi:10.1046/j.1523-1755.1999.07164.x
Apolipoprotein E phenotypes in hemodialysis patients FREE
Toshio Imura, Hideki Kimura and Fumitake Gejyo
Kidney Int 56: S245-S247; doi:10.1046/j.1523-1755.1999.07165.x
Abnormalities in lipoprotein metabolism in hemodialysis patients FREE
Michaela Königer, Thomas Quaschning, Christoph Wanner, Peter Schollmeyer and Annette Krämer-Guth
Kidney Int 56: S248-S250; doi:10.1046/j.1523-1755.1999.07166.x
Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients FREE
Yutaka Koda, Shin-Ichi Nishi, Masashi Suzuki and Yoshihei Hirasawa
Kidney Int 56: S251-S253; doi:10.1046/j.1523-1755.1999.07167.x
Phosphotyrosine of macrophage by low-density lipoproteins from hemodialysis patients FREE
Miyahiko Sonobe, Keigo Kimura, Masanori Kishino, Yoshinori Tone, Yoichi Yamada, Masatoshi Mune, Susumu Yukawa and Iwao Nishide
Kidney Int 56: S254-S255; doi:10.1046/j.1523-1755.1999.07168.x
